Drugs / Canadá
last change 3 days ago re-read 2 minutes ago

Canadá

Developed for
chronic pain syndrome
Investigated by
EMS

Trials 1 · a red edge is where a trial was stopped

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05125978 Sep 2026 → Jul 2028 chronic pain syndrome EMS Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Canadá ClinicalTrials.gov intervention name — accepted as the source's own label NCT05125978
Route Oral “1 tablet Canadá, oral;” NCT05125978